Quantum BioPharma Ltd. Pharma Provides Update from Celly Nutrition Signing a Master Distribution Agreement with FUSION Distribution Group Across Puerto Rico, the Caribbean, and Parts of Central and South America
Quantum BioPharma (NASDAQ:QNTM) has provided an update on Celly Nutrition Corp.'s recent developments. Celly Nu, led by former Coca-Cola executive John Duffy and co-chaired by ex-Celsius Holdings CEO Gerry David, has signed a master distribution agreement with FUSION Distribution Group. This partnership will introduce unbuzzd™, Celly Nu's innovative alcohol metabolism supplement, to Puerto Rico, the Caribbean, and parts of Central and South America.
unbuzzd™ is a scientifically formulated beverage product designed to support the body's natural processes for metabolizing alcohol and promoting alertness. It's currently available on Amazon as Ready-to-Mix (RTM) powder sticks, with Ready-to-Drink (RTD) cans coming soon. The partnership with FUSION, a leading brand incubator and distributor in the region, will expand unbuzzd's market presence through major retailers including Walmart, Walgreens, CVS, and Costco.
Quantum BioPharma (NASDAQ:QNTM) ha fornito un aggiornamento sugli sviluppi recenti di Celly Nutrition Corp. Celly Nu, guidata dall'ex dirigente della Coca-Cola John Duffy e co-presieduta dall'ex CEO di Celsius Holdings Gerry David, ha firmato un accordo di distribuzione principale con FUSION Distribution Group. Questa partnership introdurrà unbuzzd™, l'innovativo supplemento per il metabolismo dell'alcol di Celly Nu, in Porto Rico, nei Caraibi e in alcune parti dell'America Centrale e Meridionale.
unbuzzd™ è un prodotto bevanda scientificamente formulato, progettato per supportare i processi naturali del corpo nel metabolizzare l'alcol e promuovere la vigilanza. È attualmente disponibile su Amazon come polvere istantanea (RTM), con lattine pronte da bere (RTD) in arrivo presto. La partnership con FUSION, un importante incubatore di marchi e distributore nella regione, amplierà la presenza di unbuzzd attraverso i principali rivenditori, tra cui Walmart, Walgreens, CVS e Costco.
Quantum BioPharma (NASDAQ:QNTM) ha proporcionado una actualización sobre los recientes desarrollos de Celly Nutrition Corp. Celly Nu, liderada por el exejecutivo de Coca-Cola John Duffy y copresidida por el ex CEO de Celsius Holdings Gerry David, ha firmado un acuerdo de distribución maestra con FUSION Distribution Group. Esta asociación introducirá unbuzzd™, el innovador suplemento para el metabolismo del alcohol de Celly Nu, en Puerto Rico, el Caribe y partes de América Central y del Sur.
unbuzzd™ es un producto de bebida formulado científicamente, diseñado para ayudar a los procesos naturales del cuerpo en el metabolismo del alcohol y promover la alerta. Actualmente está disponible en Amazon en formato de sticks de polvo lista para mezclar (RTM), y pronto habrá latas listas para beber (RTD). La asociación con FUSION, un importante incubador de marca y distribuidor en la región, ampliará la presencia de unbuzzd a través de grandes minoristas como Walmart, Walgreens, CVS y Costco.
Quantum BioPharma (NASDAQ:QNTM)는 Celly Nutrition Corp의 최근 개발 사항에 대한 업데이트를 제공했습니다. Coca-Cola의 전임 임원인 John Duffy가 이끄는 Celly Nu는 ex-Celsius Holdings CEO인 Gerry David와 공동 의장을 맡아 FUSION Distribution Group과 마스터 유통 계약을 체결했습니다. 이 파트너십은 Celly Nu의 혁신적인 알코올 대사 보조제인 unbuzzd™를 푸에르토리코, 카리브해, 및 중남미의 일부 지역에 소개할 것입니다.
unbuzzd™는 알코올을 대사하고 경각심을 높이는 신체의 자연적인 과정을 지원하도록 설계된 과학적으로 포뮬라된 음료 제품입니다. 현재 Amazon에서 혼합 준비 완료(Ready-to-Mix, RTM) 파우더 스틱으로 제공되며, 곧 음료 준비 완료(Ready-to-Drink, RTD) 캔도 출시될 예정입니다. 지역의 주요 브랜드 인큐베이터이자 유통업체인 FUSION과의 파트너십은 Walmart, Walgreens, CVS 및 Costco를 포함한 주요 소매업체를 통해 unbuzzd의 시장 존재감을 확대할 것입니다.
Quantum BioPharma (NASDAQ:QNTM) a fourni une mise à jour sur les développements récents de Celly Nutrition Corp. Celly Nu, dirigée par l'ancien dirigeant de Coca-Cola John Duffy et coprésidée par l'ancien PDG de Celsius Holdings Gerry David, a signé un accord de distribution principale avec FUSION Distribution Group. Ce partenariat introduira unbuzzd™, le supplément innovant de Celly Nu pour le métabolisme de l'alcool, à Porto Rico, dans les Caraïbes et dans certaines régions d'Amérique centrale et du Sud.
unbuzzd™ est un produit de boisson formulé scientifiquement, conçu pour soutenir les processus naturels du corps dans le métabolisme de l'alcool et promouvoir l'éveil. Il est actuellement disponible sur Amazon sous forme de sticks de poudre prête à mélanger (RTM), avec des canettes prêtes à boire (RTD) qui arrivent bientôt. Le partenariat avec FUSION, un important incubateur de marques et distributeur dans la région, va accroître la présence d'unbuzzd auprès de grands détaillants tels que Walmart, Walgreens, CVS et Costco.
Quantum BioPharma (NASDAQ:QNTM) hat ein Update zu den jüngsten Entwicklungen der Celly Nutrition Corp. bereitgestellt. Celly Nu, geleitet von dem ehemaligen Coca-Cola-Manager John Duffy und mit Gerry David, dem ehemaligen CEO von Celsius Holdings, im Co-Vorsitz, hat einen Mastervertriebsvertrag mit der FUSION Distribution Group unterzeichnet. Diese Partnerschaft wird unbuzzd™, das innovative Alkoholmetabolismus-Supplement von Celly Nu, in Puerto Rico, der Karibik sowie Teilen Mittel- und Südamerikas einführen.
unbuzzd™ ist ein wissenschaftlich formuliertes Getränk, das entwickelt wurde, um die natürlichen Prozesse des Körpers zur Metabolisierung von Alkohol und zur Förderung der Wachsamkeit zu unterstützen. Es ist derzeit auf Amazon als sofort lösliche (RTM) Pulversticks erhältlich, während bald die sofort trinkbaren (RTD) Dosen folgen werden. Die Partnerschaft mit FUSION, einem führenden Markeninkubator und Distributor in der Region, wird die Marktpräsenz von unbuzzd durch große Einzelhändler wie Walmart, Walgreens, CVS und Costco erweitern.
- Expansion into new markets across Puerto Rico, the Caribbean, and parts of Central and South America
- Partnership with FUSION Distribution Group, a leading brand incubator and distributor in the region
- Access to major retail customers including Walmart, Walgreens, CVS, and Costco
- Product availability on Amazon with plans for Ready-to-Drink cans
- None.
TORONTO, ON / ACCESSWIRE / October 7, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"), provides an update by way of a news release issued by Celly Nutrition Corp. ("Celly Nu"), and its launching of unbuzzd™, an innovative beverage product that is scientifically formulated from a proprietary blend of vitamins, minerals and botanical extracts designed to support the body's natural processes for metabolizing alcohol and promoting alertness.
On October 7, 2024, Celly Nu announced signing a Master Distribution Agreement with FUSION Distribution Group across Puerto Rico, The Caribbean, and parts of Central and South America as follows:
Vancouver, BC - October 7, 2024 - Celly Nutrition Corp. ("Celly Nu" or the "Company"), led by CEO John Duffy, formerly Vice-President of National Sales of Coca-Cola, and co-chaired by Gerry David, former CEO of Celsius Holdings, has secured a master distribution agreement with FUSION Consulting Group ("Fusion"). Based in Puerto Rico, FUSION is a leading brand incubator and distributor of health-conscious food and beverages across Puerto Rico, the Caribbean, and parts of Central and South America. This partnership will bring unbuzzd™, Celly Nu's innovative alcohol metabolism supplement, to new markets through FUSION's robust distribution network.
unbuzzd's Ready-to-Mix (RTM) powder sticks are available now on Amazon in 3-packs and 18 packs, with Ready-to-Drink (RTD) 12oz cans coming soon. FUSION will handle distribution for both formats, alongside its impressive portfolio that includes CELSIUS, SHINE Water, Tona Cerveza, and Kin Whiskey.
John Duffy, CEO of Celly Nutrition Corp. stated, "Our partnership with FUSION marks a pivotal moment for unbuzzd. Their proven success in growing brands across the region will help us expand our footprint while delivering a functional, science-backed product. Eduardo Santacana and his team at FUSION are the perfect partners to help us introduce unbuzzd to consumers who seek a better way to enjoy alcohol responsibly."
Eduardo Santacana, CEO of FUSION Consulting Group, added: "It's an exciting opportunity to be part of unbuzzd's journey. This innovative product helps metabolize alcohol faster, promoting clarity and minimizing the aftereffects of drinking. We're eager to help bring unbuzzd's unique benefits to consumers across the Caribbean and beyond."
As unbuzzd™ enters key vacation destinations, where alcohol consumption is often part of the experience, the partnership with FUSION opens doors to major retail customers including Walmart, Walgreens, CVS, Costco, Sams, Farmacias Caridad, Pueblo Supermarkets, Supermax and many more.
About Celly Nutrition Corp.:
Celly Nutrition stands as a pioneering force in the wellness and recovery supplement landscape. With a commitment to innovation and quality, the company has secured an exclusive global licensing agreement with Quantum Biopharma Ltd., harnessing cutting-edge alcohol metabolizing technology for recreational uses. This strategic move positions Celly Nutrition as a leader in the development of science-driven solutions designed to enhance individual health and recovery processes, marking a new era in the support of responsible alcohol consumption.
About Fusion Distribution Group:
Fusion Consulting Group is a full-service, brand incubator distributor of Better For You! food & beverages in Puerto Rico & the Caribbean Basin. Fusion's differentiation is the passion & force by which launches & manages brands in its territory. Fusion's internal marketing department works closely with our partners to ensure a smooth and seamless integration to brand's identity, positioning and image.
Cautionary Note Regarding Forward-Looking Information
This news release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Generally, but not always, forward-looking information and statements can be identified by the use of words such as "plans", "expects", "intends", "estimates", "intends", "anticipates", or "believes" or the negative connotation thereof or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved" or the negative connotation thereof. "Forward-looking information" includes, the Company's plans to launch its RTD (Ready to Drink) 12oz cans; and the benefits of the partnership with FUSION, including the bringing of unbuzzd™ to new markets through FUSION's distribution network, the expected expansion of Celly Nu's footprint, the bringing of unbuzzd's unique benefits to consumers across the Caribbean and beyond, and the partnership with FUSION opening the doors to major retail customers in key vacation destinations.
Such forward-looking information and statements are based on numerous assumptions, including the Company having the ability to launch its RTD (Ready to Drink) 12oz cans; and the Company having the ability to realize upon the stated benefits of the partnership with FUSION.
Forward-looking information and statements also involve known and unknown risks and uncertainties and other factors, which may cause actual events or results in future periods to differ materially from any projections of future events or results expressed or implied by such forward-looking information or statements, including, the Company's inability to launch its RTD (Ready to Drink) 12oz cans; and the Company's inability to realize upon the stated benefits of the partnership with FUSION.
Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in the forward-looking information or implied by forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended.
There can be no assurance that forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated, estimated or intended. Accordingly, readers should not place undue reliance on forward-looking statements or information. The Company undertakes no obligation to update or reissue forward-looking information as a result of new information or events except as required by applicable securities laws.
The Company makes no medical, treatment or health benefit claims about unbuzzd™. The U.S. Food and Drug Administration, Health Canada or other similar regulatory authorities have not evaluated any claims regarding unbuzzd™. The efficacy of such products have not been confirmed by approved research. Rigorous scientific research and clinical trials are needed. No clinical trials for the use of the Company's proposed products have been conducted. Any references to quality, consistency, efficacy and safety of potential products do not imply that the Company verified such in clinical trials or that the Company will complete such trials.
Contacts:
Quantum BioPharma Ltd.
Zeeshan Saeed, Founder, CEO and Executive Co-Chairman of the Board, Quantum BioPharma Ltd.
Email: Zsaeed@quantumbiopharma.com
Telephone: (416) 854-8884
Investor Relations
Email: ir@quantumbiopharma.com, info@quantumbiopharma.com
Website: www.quantumbiopharma.com
Contact Information
Zeeshan Saeed
Founder, CEO and Executive Co-Chairman of the Board
zsaeed@quantumbiopharma.com
416-854-8884
SOURCE: Quantum Biopharma Ltd.
View the original press release on accesswire.com
FAQ
What is the new distribution agreement for Celly Nutrition's unbuzzd™ product?
Who are the key executives involved in Celly Nutrition Corp. (QNTM)?
What is unbuzzd™ and how is it currently available?
Which major retailers will potentially carry unbuzzd™ through the FUSION partnership?
